Spiral Therapeutics

South San Francisco, CA · Founded 2016 · Privately Held (backing)

Developer of drug therapies designed to treat inner ear disorders. Spiral Therapeutics is based in South San Francisco, CA and was founded in 2016. It was valued at $52 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $51.2 million across 3 recorded rounds; the latest was a $27.1 million early-stage round in Sep 2025.

PMV mark · valuation
$52.0M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$51.2M
Last round
Early Stage VC
Sep 2025
What is Spiral Therapeutics worth?
$52.0MPrivateMarketView mark · Oct 2026

Valued at $52.0M at its later-stage round, Apr 2026. Nothing has traded since.

Free account
More of Spiral Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Spiral Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Spiral Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Sep 2025Early Stage VC$27.1M▮
Oct 2022Early Stage VC$10.9M▮
Dec 2018Early Stage VC$8.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Spiral Therapeutics valuation

Spiral Therapeutics was valued at $52 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Spiral Therapeutics raised?

Spiral Therapeutics has raised $51.2 million across 3 recorded rounds since 2018. The largest was an $8.5 million early-stage round in Dec 2018; the most recent was a $27.1 million early-stage round in Sep 2025.

Spiral Therapeutics has filed 4 Form Ds with the SEC since 2018, most recently in Apr 2026 ($27.1 million sold to 34 investors).

How Spiral Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Spiral Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Spiral Therapeutics

What is Spiral Therapeutics worth?
Spiral Therapeutics is valued at $52.0M as of Oct 2026. Valued at $52.0M at its later-stage round, Apr 2026. Nothing has traded since.
How much has Spiral Therapeutics raised?
Spiral Therapeutics has raised $51.2M in total funding across 3 recorded rounds.
When did Spiral Therapeutics last raise?
Spiral Therapeutics last raised in Sep 2025 (Early Stage VC), raising $27.1M.